Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have been assigned a consensus rating of “Hold” from the five analysts that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $32.33.
TRUP has been the subject of several recent analyst reports. Piper Sandler decreased their price target on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research note on Friday. Evercore ISI decreased their target price on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, February 20th. Canaccord Genuity Group dropped their price target on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a report on Friday. Finally, Stifel Nicolaus lifted their price target on shares of Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research note on Friday, February 16th.
Get Our Latest Stock Report on Trupanion
Institutional Inflows and Outflows
Trupanion Stock Down 16.5 %
TRUP stock traded down $3.93 during trading on Friday, hitting $19.85. 2,327,393 shares of the stock traded hands, compared to its average volume of 683,106. The stock has a market cap of $833.60 million, a price-to-earnings ratio of -18.38 and a beta of 1.76. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63. Trupanion has a 1 year low of $18.45 and a 1 year high of $36.82. The firm’s 50 day moving average is $25.67 and its two-hundred day moving average is $26.77.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02. The firm had revenue of $306.12 million for the quarter, compared to analysts’ expectations of $300.51 million. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The business’s revenue for the quarter was up 19.4% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.60) earnings per share. On average, sell-side analysts anticipate that Trupanion will post -0.43 EPS for the current year.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles
- Five stocks we like better than Trupanion
- Canada Bond Market Holiday: How to Invest and Trade
- Appleās Earnings Show Investors Its Strength and Its Weakness
- What is an Earnings Surprise?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.